Posts by: Joana Fernandes, PhD

Joana Fernandes, PhD

Joana brings more than 8 years of academic research and experience as well as Scientific writing and editing to her role as a Science and Research writer. She also served as a Postdoctoral Researcher at the Center for Neuroscience and Cell Biology in Coimbra, Portugal, where she also received her PhD in Health Science and Technologies, with a specialty in Molecular and Cellular Biology.

October 28, 2016October 28, 2016

Nerve Cell Changes Crucial to Making Memories May Aid in Understanding Epilepsy

News

The acquisition of memories by the brain requires that neurons undergo certain physical changes. In showing exactly how these changes take place, researchers may be closer to understanding how certain ... Read more

October 14, 2016October 14, 2016

Patients with Drug-resistant Epilepsy Need Better Research and Treatment, Study Says

News

More information is needed on several aspects regarding a form of epilepsy resistant to treatments (drug-resistant epilepsy, or DRE) to provide better care and management of epileptic patients, according to a new ... Read more

October 10, 2016October 11, 2016

Brain Fats Help Mutated Protein Work to Stop Seizures in Fruit Fly Study

News

Epileptic seizures may be suppressed by increasing the concentration of specific fats in the brain, according to a study from the VIB–Flanders Interuniversity Institute for Biotechnology, in Belgium. In the ... Read more

October 3, 2016October 3, 2016

Proteins That Work to Control Brain Activity Newly Identified

News

Researchers identified a new group of proteins that help the brain to control its activity, including several proteins found to be altered in epilepsy patients. This finding sheds light on what is ... Read more

September 23, 2016September 23, 2016

Study Details Workings of Epilepsy Treatment, Fycompa, Opening Way to Improved Therapies

News

Fycompa (perampanel) is an approved treatment for epilepsy when used combination with other drugs, but its use is associated with significant side effects. Now, a study explains exactly how this drug ... Read more

August 10, 2016

First Patient Dosed in Cannabidiol Gel Clinical Trial for Epilepsy

News

Zynerba Pharmaceuticals has announced the start of the its Phase 2 STAR1 trial to assess the safety and effectiveness of ZYN002, a cannabiniol (CBD) gel for the treatment of adult epilepsy patients ... Read more